Annual Cash & Cash Equivalents
$5.58 M
-$7.60 M-57.65%
December 31, 2023
Summary
- As of February 7, 2025, EVAX annual cash & cash equivalents is $5.58 million, with the most recent change of -$7.60 million (-57.65%) on December 31, 2023.
- During the last 3 years, EVAX annual cash & cash equivalents has fallen by -$251.00 thousand (-4.30%).
- EVAX annual cash & cash equivalents is now -82.64% below its all-time high of $32.17 million, reached on December 31, 2021.
Performance
EVAX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$4.58 M
-$3.42 M-42.75%
September 1, 2024
Summary
- As of February 7, 2025, EVAX quarterly cash and cash equivalents is $4.58 million, with the most recent change of -$3.42 million (-42.75%) on September 1, 2024.
- Over the past year, EVAX quarterly cash and cash equivalents has increased by +$1.97 million (+75.66%).
- EVAX quarterly cash and cash equivalents is now -85.77% below its all-time high of $32.17 million, reached on December 31, 2021.
Performance
EVAX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
EVAX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -57.6% | +75.7% |
| 3 y3 years | -4.3% | -85.8% |
| 5 y5 years | -24.9% | -21.6% |
EVAX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -82.6% | at low | -85.8% | +75.7% |
| 5 y | 5-year | -82.6% | at low | -85.8% | +75.7% |
| alltime | all time | -82.6% | +1093.0% | -85.8% | +75.7% |
Evaxion Biotech A/S Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.58 M(-42.7%) |
| Jun 2024 | - | $7.99 M(-31.9%) |
| Mar 2024 | - | $11.73 M(+110.1%) |
| Dec 2023 | $5.58 M(-57.7%) | $5.58 M(+114.3%) |
| Sep 2023 | - | $2.60 M(-63.4%) |
| Jun 2023 | - | $7.12 M(-30.5%) |
| Mar 2023 | - | $10.24 M(-22.3%) |
| Dec 2022 | $13.18 M | $13.18 M(-26.2%) |
| Sep 2022 | - | $17.85 M(-29.3%) |
| Jun 2022 | - | $25.25 M(-19.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $31.41 M(-2.4%) |
| Dec 2021 | $32.17 M(+451.4%) | $32.17 M(+169.3%) |
| Sep 2021 | - | $11.94 M(-36.5%) |
| Jun 2021 | - | $18.80 M(-30.3%) |
| Mar 2021 | - | $26.95 M(+362.0%) |
| Dec 2020 | $5.83 M(-39.0%) | $5.83 M(-25.9%) |
| Sep 2020 | - | $7.88 M(-17.6%) |
| Dec 2019 | $9.56 M(+28.6%) | $9.56 M |
| Dec 2018 | $7.43 M(+1488.2%) | - |
| Dec 2017 | $468.00 K | - |
FAQ
- What is Evaxion Biotech A/S annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Evaxion Biotech A/S?
- What is Evaxion Biotech A/S annual cash & cash equivalents year-on-year change?
- What is Evaxion Biotech A/S quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Evaxion Biotech A/S?
- What is Evaxion Biotech A/S quarterly cash and cash equivalents year-on-year change?
What is Evaxion Biotech A/S annual cash & cash equivalents?
The current annual cash & cash equivalents of EVAX is $5.58 M
What is the all time high annual cash & cash equivalents for Evaxion Biotech A/S?
Evaxion Biotech A/S all-time high annual cash & cash equivalents is $32.17 M
What is Evaxion Biotech A/S annual cash & cash equivalents year-on-year change?
Over the past year, EVAX annual cash & cash equivalents has changed by -$7.60 M (-57.65%)
What is Evaxion Biotech A/S quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of EVAX is $4.58 M
What is the all time high quarterly cash and cash equivalents for Evaxion Biotech A/S?
Evaxion Biotech A/S all-time high quarterly cash and cash equivalents is $32.17 M
What is Evaxion Biotech A/S quarterly cash and cash equivalents year-on-year change?
Over the past year, EVAX quarterly cash and cash equivalents has changed by +$1.97 M (+75.66%)